Medical systems demonstrated to improve cancer treatment outcome.
Hlectron commercialises a platform technology, the development of which started more than a decade ago at the Physics Department (Cavendish Laboratory) of The University of Cambridge. Our medical systems harness the power of magnetic nanotechnology to generate targeted oxidative stress assault on cancer cells.
In 2020, HLectron was awarded EUR 1 million for its business innovation project TOSCA, following the award of a Seal of Excellence within the framework of The European Union’s Horizon 2020 programme.